ciprofloxacin and chloroquine

ciprofloxacin has been researched along with chloroquine in 58 studies

Research

Studies (58)

TimeframeStudies, this research(%)All Research%
pre-19901 (1.72)18.7374
1990's3 (5.17)18.2507
2000's23 (39.66)29.6817
2010's27 (46.55)24.3611
2020's4 (6.90)2.80

Authors

AuthorsStudies
Dunbar, DC; Ferreira, D; Jacob, MR; Li, XC; Muhammad, I; Tekwani, BL1
Hamann, MT; Kasanah, N; Rao, KV; Schinazi, RF; Tekwani, BL; Wahyuono, S1
Alonso, D; Donia, MS; Franzblau, SG; Garcia-Palomero, E; Hamann, MT; Khan, SI; Martinez, A; Medina, M; Peng, J; Rao, KV; Tekwani, BL; Wahyuono, S; Willett, KL1
Bharate, SB; Chauthe, SK; Jacob, MR; Khan, IA; Khan, SI; Singh, IP; Tekwani, BL; Yunus, NA1
Jacob, MR; Jain, M; Jain, R; Kaur, K; Khan, SI; Patel, SR; Patil, P; Tekwani, BL1
Ablordeppey, SY; Fan, P; Jacob, M; Khan, A; Khan, S; Li, S; Mardenborough, LG; Walker, L; Zhang, W; Zhu, XY1
Dahl, EL; Rosenthal, PJ1
Bharate, SB; Jacob, M; Khan, IA; Khan, SI; Singh, IP; Tekwani, BL1
Lombardo, F; Obach, RS; Waters, NJ1
Doerksen, RJ; Hamann, MT; Ibrahim, MA; Jacob, M; Khan, SI; Prasanna, S; Shilabin, AG1
Hamann, MT; Kasanah, N; Shilabin, AG; Tekwani, BL1
Ashfaq, MK; Jacob, MR; Joshi, VC; Khan, SI; Manly, SP; Muhammad, I; Samoylenko, V; Tekwani, BL; Walker, LA1
Ahmed, SA; Elsohly, MA; Khan, IA; Radwan, MM; Ross, SA; Slade, D1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Hamann, MT; Kudrimoti, S; Peng, J; Tekwani, BL; Wahba, AE1
Ahmed, SA; Elsohly, MA; Galal, AM; Gul, W; Jacob, MR; Khan, SI; Radwan, MM; Ross, SA; Slade, D; Tekwani, BL1
Anquetin, G; Biot, C; Dive, D; Dubar, F; Khalife, J; Pradines, B1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choo, YM; Doerksen, RJ; Gertsch, J; Hamann, MT; Jacob, MR; Khan, SI; Kudrimoti, S; Madgula, V; Mayer, AM; Odde, S; Peng, J; Pennaka, HK; Prasanna, S; Rao, KV; Tekwani, BL; Tu, LC; Wang, B1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Ferreira, D; Fronczek, FR; Jacob, M; Khan, SI; Kumarihamy, M; Nanayakkara, NP1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Chen, X; Lin, X; Skolnik, S; Wang, J1
Sen, S; Sinha, N1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Jacob, MR; Jain, M; Jain, R; Kaur, K; Khan, SI; Singh, PP; Singh, S; Tekwani, BL1
Duke, SO; Ferreira, D; Jacob, M; Khan, SI; Kumarihamy, M; Nanayakkara, NP; Tekwani, BL1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Cutler, HG; Cutler, SJ; Dugan, FM; Gao, J; Hill, RA; Jacob, MR; Khan, SI; León, F; Lupien, S; Radwan, MM; Tekwani, BL; Wang, X1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Kalaria, PN; Raval, DK; Satasia, SP1
Karad, SC; Purohit, VB; Raval, DK1
Karad, SC; Purohit, VB; Raval, DK; Thakkar, VR; Thakor, P1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y1
Amesty, Á; Anaissi-Afonso, L; Estévez-Braun, A; Hueso-Falcón, I; Lorenzo-Castrillejo, I; Machín, F1
Sankar, C; Umamatheswari, S1
Kashaw, SK; Kashaw, V; Mishra, M; Mishra, VK1
Doshi, H; Ray, A; Thakkar, SS; Thakor, P1
Doshi, H; Ray, A; Thakkar, SS; Thakkar, VR; Thakor, P1
Carvalho, P; Cutler, SJ; Dale, OR; Elokely, KM; ElSohly, MA; Galal Osman, A; Gul, W; Husni, AS; Khan, S; Klein, ML; Radwan, M; Ross, SA; Slade, D; Yadav, VK1
Chu, XM; Gong, KK; Liang, LL; Liu, W; Sun, KL; Wang, C; Zhao, CY1
Dana, S; Dhar, SK; Gurung, SK; Kumar, S; Mondal, N; Mukhopadhyay, P; Valissery, P1
Alajlani, M; Bauer, R; Belaj, F; Brantner, A; Dolensky, J; Hochegger, P; Kaiser, M; Kretschmer, N; Mäser, P; Mohsin, NU; Petritsch, M; Saf, R; Schühly, W; Seebacher, W; Weis, R1
Daraji, DG; Jayanthi, S; Patel, HD; Pithawala, EA; Rajani, DP; Rajani, SD1
Bia, FJ; Divo, AA; Patton, CL; Sartorelli, AC1
Rollof, J; Vinge, E1
Biswas, S; Sharma, AK; Tripathi, KD; Valecha, N1
Singh, PS1
Hoelscher, M; Löscher, T1
Ono, C; Tanaka, M1
Adegbolagun, OM; Anumudu, CI; Kazzim, OJ; Osho, O1
Falkenberg, M; Scotti da Silva-Colombeli, A1
Agbasi, PU; Brown, SA; Elo-Ilo, J; Ilo, EC; Ilondu, NA; Okwoli, N; Orisakwe, OE1
Abiodun, OO; Gbotosho, GO; Happi, CT; Oduola, AM; Sowunmi, A; Woranola, O1
Abiodun, OO; Akinola, O; Falajiki, YF; Gbotosho, GO; Happi, CT; Sowunmi, A1
Beberok, A; Boryczka, S; Marciniec, K; Pęcak, P; Wrześniok, D1

Reviews

2 review(s) available for ciprofloxacin and chloroquine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Quinoline and quinolone dimers and their biological activities: An overview.
    European journal of medicinal chemistry, 2019, Jan-01, Volume: 161

    Topics: Anti-Bacterial Agents; Antimalarials; Antineoplastic Agents; Bacteria; Dimerization; Humans; Neoplasms; Quinolines; Quinolones

2019

Other Studies

56 other study(ies) available for ciprofloxacin and chloroquine

ArticleYear
Antimicrobial and antiparasitic (+)-trans-hexahydrodibenzopyrans and analogues from Machaerium multiflorum.
    Journal of natural products, 2003, Volume: 66, Issue:6

    Topics: Animals; Anti-Infective Agents; Antimalarials; Antiparasitic Agents; Benzopyrans; Candida albicans; Fabaceae; Inhibitory Concentration 50; Leishmania donovani; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Peru; Plant Bark; Plants, Medicinal; Plasmodium falciparum; Staphylococcus aureus; Stereoisomerism

2003
Three new manzamine alkaloids from a common Indonesian sponge and their activity against infectious and tropical parasitic diseases.
    Journal of natural products, 2004, Volume: 67, Issue:8

    Topics: Alkaloids; Animals; Anti-HIV Agents; Anti-Infective Agents; Antimalarials; Antiprotozoal Agents; Carbolines; Indonesia; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Porifera

2004
Manzamine B and E and ircinal A related alkaloids from an Indonesian Acanthostrongylophora sponge and their activity against infectious, tropical parasitic, and Alzheimer's diseases.
    Journal of natural products, 2006, Volume: 69, Issue:7

    Topics: Alzheimer Disease; Animals; Female; Glycogen Synthase Kinase 3; HIV-1; Humans; Indole Alkaloids; Indonesia; Inhibitory Concentration 50; Leishmania donovani; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Oryzias; Plasmodium falciparum; Porifera; Structure-Activity Relationship

2006
Antiprotozoal and antimicrobial activities of O-alkylated and formylated acylphloroglucinols.
    Bioorganic & medicinal chemistry, 2007, Jan-01, Volume: 15, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antiprotozoal Agents; Candida albicans; Cell Proliferation; Cell Survival; Chlorocebus aethiops; Cryptococcus neoformans; Epithelial Cells; Leishmania donovani; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Phloroglucinol; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship; Vero Cells

2007
Synthesis, antimalarial, antileishmanial, antimicrobial, cytotoxicity, and methemoglobin (MetHB) formation activities of new 8-quinolinamines.
    Bioorganic & medicinal chemistry, 2007, Jan-15, Volume: 15, Issue:2

    Topics: Aminoquinolines; Animals; Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antiparasitic Agents; Bacteria; Chlorocebus aethiops; Erythrocytes; Fungi; Humans; Indicators and Reagents; L-Lactate Dehydrogenase; Leishmania donovani; Magnetic Resonance Spectroscopy; Methemoglobin; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Structure-Activity Relationship; Vero Cells

2007
Synthesis and evaluation of isosteres of N-methyl indolo[3,2-b]-quinoline (cryptolepine) as new antiinfective agents.
    Bioorganic & medicinal chemistry, 2007, Jan-15, Volume: 15, Issue:2

    Topics: Alkaloids; Animals; Anti-Infective Agents; Antimalarials; Antiparasitic Agents; Bacteria; Cell Line; Cell Survival; Chemical Phenomena; Chemistry, Physical; Chlorocebus aethiops; Fungi; Humans; Indicators and Reagents; Indole Alkaloids; Indoles; Isomerism; Leishmania donovani; Magnetic Resonance Spectroscopy; Mice; Microbial Sensitivity Tests; Plasmodium falciparum; Quinolines; Structure-Activity Relationship; Vero Cells

2007
Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:10

    Topics: Animals; Anti-Bacterial Agents; Antimalarials; Drug Resistance; Flow Cytometry; Green Fluorescent Proteins; Plasmodium falciparum; Protein Synthesis Inhibitors; Topoisomerase II Inhibitors

2007
S-Euglobals: biomimetic synthesis, antileishmanial, antimalarial, and antimicrobial activities.
    Bioorganic & medicinal chemistry, 2008, Feb-01, Volume: 16, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Biomimetic Materials; Leishmania donovani; Magnetic Resonance Spectroscopy; Molecular Structure; Mycobacterium avium Complex; Phloroglucinol; Plasmodium falciparum; Staphylococcus aureus; Structure-Activity Relationship; Terpenes

2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
2-N-Methyl modifications and SAR studies of manzamine A.
    Bioorganic & medicinal chemistry, 2008, Jul-15, Volume: 16, Issue:14

    Topics: Animals; Antimalarials; Carbazoles; Carbolines; Chlorocebus aethiops; Erythrocytes; Fibroblasts; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Inhibitory Concentration 50; Kidney; Methylation; Models, Molecular; Plasmodium falciparum; Structure-Activity Relationship; Vero Cells

2008
Kinetic studies and bioactivity of potential manzamine prodrugs.
    Journal of natural products, 2008, Volume: 71, Issue:7

    Topics: Administration, Oral; Animals; Antimalarials; Candida albicans; Carbolines; Chlorocebus aethiops; Cryptococcus neoformans; Disease Models, Animal; Inhibitory Concentration 50; Leishmania donovani; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Plasmodium falciparum; Prodrugs; Vero Cells

2008
Indolizidine, antiinfective and antiparasitic compounds from Prosopis glandulosa var. glandulosa.
    Journal of natural products, 2009, Volume: 72, Issue:1

    Topics: Animals; Anti-Infective Agents; Antiparasitic Agents; Aspergillus fumigatus; Brain; Candida albicans; Chloroquine; Cryptococcus neoformans; Disease Models, Animal; Drug Screening Assays, Antitumor; Humans; Indolizidines; Inhibitory Concentration 50; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Molecular Structure; Nevada; Plants, Medicinal; Plasmodium berghei; Prosopis

2009
Biologically active cannabinoids from high-potency Cannabis sativa.
    Journal of natural products, 2009, May-22, Volume: 72, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Aspergillus fumigatus; Candida; Cannabinoids; Cannabis; Chlorocebus aethiops; Escherichia coli; Gas Chromatography-Mass Spectrometry; Leishmania donovani; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Plants, Medicinal; Plasmodium falciparum; Pseudomonas aeruginosa

2009
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Structure-activity relationship studies of manzamine A: amidation of positions 6 and 8 of the beta-carboline moiety.
    Bioorganic & medicinal chemistry, 2009, Nov-15, Volume: 17, Issue:22

    Topics: Administration, Oral; Amides; Animals; Antimalarials; Carbazoles; Carbolines; Male; Mice; Mycobacterium avium Complex; Plasmodium berghei; Plasmodium falciparum; Structure-Activity Relationship

2009
Antiprotozoal, anticancer and antimicrobial activities of dihydroartemisinin acetal dimers and monomers.
    Bioorganic & medicinal chemistry, 2009, Dec-01, Volume: 17, Issue:23

    Topics: Acetals; Antifungal Agents; Antineoplastic Agents; Antiprotozoal Agents; Artemisinins; Cell Line, Tumor; Cryptococcus neoformans; Dimerization; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Plasmodium falciparum; Spectrometry, Mass, Electrospray Ionization

2009
Enhancement of the antimalarial activity of ciprofloxacin using a double prodrug/bioorganometallic approach.
    Journal of medicinal chemistry, 2009, Dec-24, Volume: 52, Issue:24

    Topics: Aminoquinolines; Antimalarials; Ciprofloxacin; Ferrous Compounds; Metallocenes; Plasmodium falciparum; Prodrugs

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Structure-activity relationship and mechanism of action studies of manzamine analogues for the control of neuroinflammation and cerebral infections.
    Journal of medicinal chemistry, 2010, Jan-14, Volume: 53, Issue:1

    Topics: Animals; Anti-Infective Agents; Carbazoles; Cerebellar Diseases; Indole Alkaloids; Mice; Microbial Sensitivity Tests; Molecular Structure; Neurogenic Inflammation; Porifera; Stereoisomerism; Structure-Activity Relationship

2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Bioactive 1,4-dihydroxy-5-phenyl-2-pyridinone alkaloids from Septoria pistaciarum.
    Journal of natural products, 2010, Jul-23, Volume: 73, Issue:7

    Topics: Alkaloids; Animals; Antimalarials; Ascomycota; Chlorocebus aethiops; Chloroquine; Crystallography, X-Ray; Methicillin-Resistant Staphylococcus aureus; Molecular Conformation; Molecular Structure; Plasmodium falciparum; Pyridones

2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:2

    Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity

2011
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:2

    Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship

2011
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Amino acid, dipeptide and pseudodipeptide conjugates of ring-substituted 8-aminoquinolines: synthesis and evaluation of anti-infective, β-haematin inhibition and cytotoxic activities.
    European journal of medicinal chemistry, 2012, Volume: 52

    Topics: Amino Acids; Aminoquinolines; Animals; Anti-Infective Agents; Chemistry Techniques, Synthetic; Chlorocebus aethiops; Dipeptides; Fungi; Hemeproteins; Leishmania donovani; Mice; Peptidomimetics; Plasmodium falciparum; Vero Cells

2012
Antiprotozoal and antimicrobial compounds from the plant pathogen Septoria pistaciarum.
    Journal of natural products, 2012, May-25, Volume: 75, Issue:5

    Topics: Alkaloids; Animals; Anti-Infective Agents; Antimalarials; Antiprotozoal Agents; Ascomycota; Aspergillus fumigatus; Candida albicans; Candida glabrata; Chlorocebus aethiops; Chloroquine; Cryptococcus neoformans; Escherichia coli; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium avium Complex; Plasmodium falciparum; Pseudomonas aeruginosa; Staphylococcus aureus; Vero Cells

2012
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Antimicrobial and antiprotozoal activities of secondary metabolites from the fungus Eurotium repens.
    Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, 2012, Volume: 21, Issue:10

    Topics:

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Synthesis, characterization and pharmacological screening of some novel 5-imidazopyrazole incorporated polyhydroquinoline derivatives.
    European journal of medicinal chemistry, 2014, May-06, Volume: 78

    Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymers; Pyrazoles; Quinolines; Structure-Activity Relationship

2014
Design, synthesis and characterization of fluoro substituted novel pyrazolylpyrazolines scaffold and their pharmacological screening.
    European journal of medicinal chemistry, 2014, Sep-12, Volume: 84

    Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Drug Design; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrazoles; Structure-Activity Relationship

2014
Novel morpholinoquinoline nucleus clubbed with pyrazoline scaffolds: Synthesis, antibacterial, antitubercular and antimalarial activities.
    European journal of medicinal chemistry, 2016, Apr-13, Volume: 112

    Topics: Anti-Infective Agents; Antimalarials; Antitubercular Agents; Bacteria; Bacterial Infections; Fungi; Humans; Malaria, Falciparum; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycoses; Plasmodium falciparum; Pyrazoles; Quinolines; Structure-Activity Relationship; Tuberculosis

2016
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
    Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16

    Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone

2016
Synthesis and biological evaluation of naphthoquinone-coumarin conjugates as topoisomerase II inhibitors.
    Bioorganic & medicinal chemistry letters, 2017, 02-01, Volume: 27, Issue:3

    Topics: Coumarins; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Humans; Molecular Structure; Naphthoquinones; Structure-Activity Relationship; Topoisomerase II Inhibitors

2017
Synthesis, identification and in vitro biological evaluation of some novel quinoline incorporated 1,3-thiazinan-4-one derivatives.
    Bioorganic & medicinal chemistry letters, 2017, 02-01, Volume: 27, Issue:3

    Topics: Anti-Bacterial Agents; Antimalarials; Antitubercular Agents; Clostridium tetani; Gram-Negative Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Plasmodium falciparum; Quinolines; Spectroscopy, Fourier Transform Infrared; Structure-Activity Relationship; Thiazines

2017
Synthesis of 1,3,5-trisubstituted pyrazolines as potential antimalarial and antimicrobial agents.
    Bioorganic & medicinal chemistry, 2017, 03-15, Volume: 25, Issue:6

    Topics: Anti-Infective Agents; Antimalarials; Microbial Sensitivity Tests; Proton Magnetic Resonance Spectroscopy; Pyrazoles; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared

2017
1,2,4-Triazole and 1,3,4-oxadiazole analogues: Synthesis, MO studies, in silico molecular docking studies, antimalarial as DHFR inhibitor and antimicrobial activities.
    Bioorganic & medicinal chemistry, 2017, 08-01, Volume: 25, Issue:15

    Topics: Anti-Infective Agents; Antimalarials; Folic Acid Antagonists; Molecular Docking Simulation; Oxadiazoles; Spectrum Analysis; Triazoles

2017
Benzothiazole analogues: Synthesis, characterization, MO calculations with PM6 and DFT, in silico studies and in vitro antimalarial as DHFR inhibitors and antimicrobial activities.
    Bioorganic & medicinal chemistry, 2017, 10-15, Volume: 25, Issue:20

    Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Benzothiazoles; Cell Survival; Computer Simulation; Dose-Response Relationship, Drug; Folic Acid Antagonists; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Plasmodium falciparum; Quantum Theory; Schizosaccharomyces; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase

2017
Bioactive products from singlet oxygen photooxygenation of cannabinoids.
    European journal of medicinal chemistry, 2018, Jan-01, Volume: 143

    Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antiprotozoal Agents; Bacteria; Cannabinoids; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Fungi; Humans; Leishmania major; Microbial Sensitivity Tests; Parasitic Sensitivity Tests; Photochemical Processes; Plasmodium falciparum; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Singlet Oxygen

2018
Synthesis of Novel Ciprofloxacin-Based Hybrid Molecules toward Potent Antimalarial Activity.
    ACS medicinal chemistry letters, 2020, Jul-09, Volume: 11, Issue:7

    Topics:

2020
Preparation of new 1,3-dibenzyl tetrahydropyridinylidene ammonium salts and their antimicrobial and anticellular activities.
    European journal of medicinal chemistry, 2021, Jan-15, Volume: 210

    Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Antineoplastic Agents; Candida albicans; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Epidermis; Escherichia coli; Female; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pseudomonas aeruginosa; Quaternary Ammonium Compounds; Rats; Salts; Staphylococcus aureus; Structure-Activity Relationship

2021
Structure based design, synthesis, and biological evaluation of imidazole derivatives targeting dihydropteroate synthase enzyme.
    Bioorganic & medicinal chemistry letters, 2021, 03-15, Volume: 36

    Topics: Anti-Bacterial Agents; Dihydropteroate Synthase; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Imidazoles; Ligands; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin-Resistant Enterococci

2021
Activity of fluoroquinolone antibiotics against Plasmodium falciparum in vitro.
    Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:8

    Topics: Aminocoumarins; Animals; Anti-Infective Agents; Chloroquine; Ciprofloxacin; Coumarins; Drug Interactions; Drug Resistance; Enoxacin; Fluoroquinolones; Nalidixic Acid; Norfloxacin; Novobiocin; Ofloxacin; Oxolinic Acid; Pefloxacin; Plasmodium falciparum; Tetracycline; Topoisomerase II Inhibitors

1988
Neurologic adverse effects during concomitant treatment with ciprofloxacin, NSAIDS, and chloroquine: possible drug interaction.
    The Annals of pharmacotherapy, 1993, Volume: 27, Issue:9

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Chloroquine; Ciprofloxacin; Dizziness; Drug Interactions; Drug Therapy, Combination; Female; Humans; Peripheral Nervous System Diseases; Syncope

1993
In vitro activity of fluoroquinolones against chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.
    Indian journal of malariology, 1993, Volume: 30, Issue:2

    Topics: Animals; Chloroquine; Ciprofloxacin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Plasmodium falciparum

1993
Coexistence of enteric fever with malaria.
    The Journal of the Association of Physicians of India, 1995, Volume: 43, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antimalarials; Brain Diseases; Chloroquine; Ciprofloxacin; Drug Resistance; Humans; Malaria, Falciparum; Quinine; Tetracycline; Typhoid Fever

1995
Advice for travelers.
    The Medical letter on drugs and therapeutics, 2002, Apr-15, Volume: 44, Issue:1128

    Topics: Africa; Altitude Sickness; Asia; Chloroquine; Ciprofloxacin; Contraindications; Diarrhea; Female; Hepatitis A; Humans; Immunization; Loperamide; Malaria; Pregnancy; Travel; Viral Vaccines

2002
[Malaria--case report].
    Deutsche medizinische Wochenschrift (1946), 2003, Jun-06, Volume: 128, Issue:23

    Topics: Adult; Anti-Infective Agents; Antidiarrheals; Antimalarials; Chloroquine; Ciprofloxacin; Diarrhea; Emergencies; Fluid Therapy; Glasgow Coma Scale; Humans; Loperamide; Malaria, Cerebral; Malaria, Falciparum; Male; Mefloquine; Nigeria; Parasitemia; Positive-Pressure Respiration; Proguanil; Quinine; Respiratory Distress Syndrome; Travel

2003
Binding characteristics of fluoroquinolones to synthetic levodopa melanin.
    The Journal of pharmacy and pharmacology, 2003, Volume: 55, Issue:8

    Topics: Binding Sites; Chloroquine; Ciprofloxacin; Drug Interactions; Enoxacin; Fluoroquinolones; Levodopa; Levofloxacin; Melanins; Monophenol Monooxygenase; Norfloxacin; Ofloxacin; Quinolones; Timolol

2003
Additive effects of ciprofloxacin on the in-vitro activity of chloroquine against a clinical isolate of Plasmodium falciparum.
    Annals of tropical medicine and parasitology, 2006, Volume: 100, Issue:7

    Topics: Animals; Antimalarials; Chloroquine; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Schizonts

2006
Analytical interferences of drugs in the chemical examination of urinary protein.
    Clinical biochemistry, 2007, Volume: 40, Issue:13-14

    Topics: Chloroquine; Ciprofloxacin; Clinical Laboratory Techniques; Humans; Pharmaceutical Preparations; Proteinuria; Quinine; Reagent Strips; Reproducibility of Results; Sensitivity and Specificity

2007
Effect of chloroquine on the bioavailability of ciprofloxacin in man.
    Journal of controlled release : official journal of the Controlled Release Society, 2006, Nov-28, Volume: 116, Issue:2

    Topics: Adult; Anti-Infective Agents; Antimalarials; Biological Availability; Chloroquine; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Interactions; Humans; Male

2006
Interaction between ciprofloxacin and chloroquine in mice infected with chloroquine resistant Plasmodium berghei: interaction between ciprofloxacin and chloroqune.
    Parasitology research, 2012, Volume: 110, Issue:2

    Topics: Animals; Antimalarials; Chloroquine; Ciprofloxacin; Disease Models, Animal; Drug Resistance; Drug Therapy, Combination; Malaria; Male; Mice; Parasitemia; Plasmodium berghei; Survival Analysis; Treatment Outcome

2012
Amodiaquine-Ciprofloxacin: a potential combination therapy against drug resistant malaria.
    Parasitology, 2015, Volume: 142, Issue:6

    Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Malaria; Male; Mice; Plasmodium berghei

2015
Ciprofloxacin and moxifloxacin could interact with SARS-CoV-2 protease: preliminary in silico analysis.
    Pharmacological reports : PR, 2020, Volume: 72, Issue:6

    Topics: Antiviral Agents; Binding Sites; Chloroquine; Ciprofloxacin; Coronavirus 3C Proteases; COVID-19; COVID-19 Drug Treatment; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Moxifloxacin; Nelfinavir; Protein Binding; SARS-CoV-2

2020